1,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
US-2026028356-A1 · Jan 29, 2026 · US
Yu Yiyun is listed as an inventor on 10 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Yu Yiyun |
| Total patents | 10 |
| First publication | Feb 21, 2019 |
| Latest publication | Jan 29, 2026 |
Publications ranked by popularity score, then publication date.
US-2026028356-A1 · Jan 29, 2026 · US
US-2025084099-A1 · Mar 13, 2025 · US
US-2025066388-A1 · Feb 27, 2025 · US
US-2023312601-A1 · Oct 5, 2023 · US
US-2023234971-A1 · Jul 27, 2023 · US
US-2022259226-A1 · Aug 18, 2022 · US
US-2021292339-A1 · Sep 23, 2021 · US
US-2020255451-A1 · Aug 13, 2020 · US
US-2020010480-A1 · Jan 9, 2020 · US
US-2019055264-A1 · Feb 21, 2019 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Abbvie Inc | 10 |
| Abbvie Deutschland | 5 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D519/00 | 8 |
| A61P35/00 | 7 |
| C07D495/16 | 5 |
| A61K31/519 | 5 |
| C07D498/18 | 5 |